期刊文献+

严重脓毒症患儿血小板减少原因剖析及处理对策分析 被引量:3

The reasons of Thrombocytopenia and its management in children with severe sepsis
下载PDF
导出
摘要 目的结合血常规、凝血功能及骨髓细胞学检查,探讨严重脓毒症患儿血小板减少的原因及临床处理措施。方法 72例严重脓毒症患儿根据预后分为死亡组及存活组,对血小板计数变化与预后关系进行分析;结合凝血功能监测与骨髓细胞学检查分析血小板减少的原因。结果死亡组与存活组相比,入院当天及入院后第7天血小板计数差异有统计学意义(P<0.05)。29例血小板减少患儿中,20例(68.97%)伴有凝血功能异常;9例(31.03%)骨髓巨核系成熟障碍;13例血小板<50×109/L中给予积极处理11例(84.62%),纠正7例(63.64%),死亡4例(36.36%);未能积极处理2例(15.38%),全部死亡。结论血小板持续进行性下降提示预后差。血小板减少有两大原因,一是凝血功能障碍致血小板过度消耗;二是骨髓巨核系成熟障碍。二者处理措施有别,针对病因积极处理可显著改善预后。 Objective To investigate the reasons of thrombocytopenia and its therapy strategy in children with severe sepsis by monitoring peripheral blood routine test,myelogram and coagulation function evaluation.Methods 72 patients of children with severe sepsis were divided into two groups according to survival(n=58)or death(n=14).The relationship of the dynamic changes of blood platelets count and the prognosis between the two groups was analyzed.Combined with coagulation function examination and marrow morphology analysis,the reasons of thrombocytopenia in sepsis were investigated.Results There was a significant difference of blood platelets count on the day of admission and 7th day after admission between the survival group and the death group.In the 29 children with thrombocytopenia,20 cases(68.97%) were accompanied with coagulation disorder and 9 cases(31.03%) with megakaryocytes dysmaturity of bone marrow.In the 13 children with PLT50×109/L,11 cases(84.62%) were given active management,and their blood platelets count was corrected in 7 cases(63.64%),4 cases died(36.36%),while 2 cases(15.38%) without active management died both.Conclusion The continuous decline of peripheral blood platelets count prognosticated poor prognosis.There were two main causes for thrombocytopenia,the first one was coagulation disorder and microthrombosis inducing platelets excessively consumed,and the other was that megakaryocytes dysmaturity of bone marrow.The prognosis was significantly improved by active management aimed directly at different etiology.
出处 《湖南中医药大学学报》 CAS 2012年第10期71-73,共3页 Journal of Hunan University of Chinese Medicine
关键词 严重脓毒症 血小板减少 弥漫性血管内凝血 Severe sepsis Thrombocytopenia Disseminated intravascular coagulation
  • 相关文献

参考文献10

  • 1邵敏,刘宝,王锦权,陶晓根,周树生,金魁,张翠萍.脓毒症患者CD4^+CD25^+调节性T细胞检测的临床意义[J].湖南中医药大学学报,2011,31(4):8-10. 被引量:13
  • 2林霞,于永慧.蛋白C通路在严重脓毒症炎症-凝血交叉对话中的作用及临床对策[J].中华急诊医学杂志,2010,19(11):1228-1230. 被引量:5
  • 3赵祥文.脓毒症的诊断与治疗[J].实用儿科临床杂志,2008,23(18):1397-1399. 被引量:8
  • 4Gunter OL Jr, Au BK,Isbell JM,et al.Optimizing outcomes in damage control resuscitation:identifying blood product ratios associated with improved survival[J].J Trauma,2008,65(3):527-534.
  • 5Levi M,Toh CH,Thachil J, et al.Guidelines for the diagnosis and management of isseminated intravascular coagulation[J].Br J Haematol,2009,145( 1 ):24-33.
  • 6Blit PH,McClung WG,Brash JL,et al.Platelet inhibition and endothelial cell adhesion on elastin-like polypeptide surface modified materials[J].Biomaterials, 2011,32(25):5 790-5 800.
  • 7Karapinar B, Yilmaz D, Balkan C, et al. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: laemoplaagocytic lymphohistiocytosis [J]. Pediatr Crit Care Med, 2009, 10(3): 285-290.
  • 8李敏,于永慧.严重脓毒症血管致内皮细胞损伤与临床对策研究[J].中华儿科杂志,2011,49(8):603-606. 被引量:10
  • 9W Faviere,T Boechat.Sepsis: thrombocytopenia is bad,not recovering thrombocytopenia is too bad[J].Critical Care,2011,15( 1 ):440.
  • 10Levi M.The coagulant response in sepsis and inflammation[J]. Hamostaseologie,2010,30( 1 ): 10-12.

二级参考文献62

共引文献27

同被引文献59

  • 1无.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中国小儿急救医学,2006,13(4):313-315. 被引量:38
  • 2Snider RH,Nylen ES,Becker KL . Prpcalcitonin and its Compo-nentpeptides in systemic inflammation : immunochemical Character-ization [J] . J Investig med,1997, 45(9) :552-560.
  • 3Blit PH, Mcelung WG, Brash JL, et al. Platelet inhibition and en-dothelial cell adhesion on elastin-like polypeptide surface modifiedmaterials [ J]. Biomaterials,2011,32(25) :5790-5800.
  • 4Akinosoglou K,Alexopoulos D.Use of antiplatelet agents in sepsis:aglimpse into the future[J].Thromb Res,2014,133(2):131-138.
  • 5Iwaszko-Simonik A,Niedzwiedz A,Graczyk S,et al.Expression of surface platelet receptors(CD62Pand CD41/61)in horses with recurrent airway obstruction(RAO)[J].Vet Immunol Immunopathol,2015,164(1-2):87-92.
  • 6Semple J W,Italiano J E Jr,Freedman J.Platelets and the immune continuum[J].Nat Rev Immunol,2011,11(4):264-274.
  • 7Katz J N,Kolappa K P,Becker R C.Beyond thrombosis:the versatile platelet in critical illness[J].Chest,2011,139(3):658-668.
  • 8Blit P H,McClung W G,Brash J L,et al.Platelet inhibition and endothelial cell adhesion on elastin-like polypeptide surface modified materials[J].Biomaterials,2011,32(25):5790-5800.
  • 9Johansson M W,Han S T,Gunderson K A,et al.Platelet activation,P-selectin,and eosinophil beta1-integrin activation in asthma[J].Am J Respir Crit Care Med,2012,185(5):498-507.
  • 10Semeraro N,Ammollo C T,Semeraro F,et al.Coagulopathy of Acute Sepsis[J].Semin Thromb Hemost,2015,41(6):650-658.

引证文献3

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部